...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: AHA 2018
3
Nov 09, 2018 08:43AM
1
Nov 09, 2018 12:43PM
4
Nov 10, 2018 05:02PM
4
bfw
Nov 10, 2018 06:45PM
4
Nov 10, 2018 10:13PM
5
Nov 10, 2018 11:04PM
3
Nov 11, 2018 05:03AM

"RVX has multiple MOA's and Amarin maybe none."

There is abundant research on the various and potential cardioprotective properties of omega-3 fatty acids. Many well documented MOAs for omega-3s like Vascepa. Lots of potential pathways modulated by apabetalone and Vascepa, but uncertain which one(s) are responsible for any MACE reduction.

 

2
Nov 11, 2018 08:53AM
1
Nov 11, 2018 10:17AM
5
Nov 11, 2018 10:41AM
3
Nov 11, 2018 03:21PM
5
Nov 11, 2018 09:56PM
4
Nov 11, 2018 11:46PM
4
Nov 12, 2018 07:32AM
2
Nov 12, 2018 08:07AM
4
Nov 12, 2018 09:22AM
1
Nov 12, 2018 11:29AM
3
Nov 12, 2018 11:49AM
2
Nov 12, 2018 08:48PM
Share
New Message
Please login to post a reply